By January 2007, in Malta, when the idea of the original conversation, the PVRI, had become a reality, a new conversation began. Led by Jason Yuan, the attendees discussed and debated the necessity of the PVRI having its own "voice" in print. This led irst to the launching in 2008 of the PVRI Review and then, only 3 years later, to the publication both of this journal, Pulmonary Circulation, aimed speci ically at the pulmonary circulation and "A single conversation across the table with a wise man is better than ten years mere study of books." -Henry Wadsworth Longfellow (1807-1882)
What the 17th-Century English poet said about people in general, that "No man is an island, entire of itself; every man is a piece of the continent, a part of the main," [1] is especially true for doctors and all the other people in all the medical professions. And on that "continent" called Medicine, the single most crucial medical tool is: conversations.
Spoken words are like oxygen, so common as to be ignored but essential for life. A recent study found that, on average, people speak about 16,000 words per day. [2] But speaking is not at all the same as having a conversation. Professional organizations' meetings often feature speakers-one person talking, multiple people listening. Conversations, in contrast, are interactive, everyone having the opportunity both to speak and to listen. In Medicine, the best meetings and conferences are conversation-based, not speakerbased.
It is for precisely that reason that the Grover Conference is today the world's most in luential scienti ic meeting focusing on the pulmonary circulation, gas exchange, and pulmonary vascular diseases (PVD). As E. Kenneth Weir, W. Wagner Wiltz Jr. and Stephen L. Archer point out in this issue of Pulmonary Circulation, in their historical review of the 15 Grover Conferences held in Colorado since the irst one in 1984, the Conference is named for a man who was, and remains, not only a pioneer and innovator in the profession, but also a master of the art of conversation: a mentor. Robert F. Grover "was also an inspirational mentor and the Conference celebrates both his scienti ic interests and his tradition of mentorship." Signi icantly, the attendees at each Grover Conference include both leaders and beginners, both the "big names" of today and the young, promising investigators who, thanks in large part to conversations like those at such conferences, will be the big names of tomorrow.
We welcome and salute the newest venue for the conversation-based advancement of our ield, the Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ), whose members held their inaugural scienti ic meeting in Sydney on 25 November 2011. Signi icantly, 2 of the PHSANZ's 4 mission goals have to do with people speaking and listening to each other: ongoing pulmonary hypertension education, to pulmonary vascular diseases, and a 1,690-page Textbook of Pulmonary Vascular Disease. [4] This trio of publications illustrate the crucial point that many of Medicine's most important conversations occur in print. Indeed, the point was made literally in the "Welcome" editorial in the inaugural issue: "Pulmonary Circulation: A new venue for communicating your indings, ideas and perspectives," the key word being "communicating."
Look at the references listed for each article in this journal, and what you are seeing, in fact, are the speakers to whom the article's authors listened to before they began to speak in print themselves. The wonder and magic of such conversations is that they are not bound by time.
For one example, all articles ever published on DNA may be viewed as contributions to the conversation started by James Watson and Francis Crick in their single-page article published 58 years ago. [5] whether a pendulum clock high on a mountain told the same time as one at sea level. [6] To facilitate further conversion, we present the Abstracts segment in this issue of Pulmonary Circulation. Submissions were received by physicians, physician scientists and investigators from the 2011 Grover Conference, the 5 th Scienti ic Workshops and Debates of the Pulmonary Vascular Research Institute (PVRI), and the Inaugural Scienti ic Meeting of the Pulmonary Hypertension Society of Australia and New Zealand (PHSANZ). The international conversation among our scholars from different disciplines and across multiple geographic locations will contribute greatly to the global awareness of Pulmonary Vascular Disease.
